Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New.
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Seller: Mispah books, Redhill, SURRE, United Kingdom
US$ 202.58
Quantity: 1 available
Add to basketpaperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Print on Demand.
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND.
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Walimbe ChaitanyaMr. Chaitanya Walimbe is a M. Pharma (Pharmaceutics) researcher from Appasaheb Birnale college of pharmacy under Shivaji University, Kolhapur, India. He has completed his major research work in Formulation and Evalua.
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Lipid-based drug delivery systems are expected as promising oral carriers because of their potential to increase the solubility and improve oral bioavailability of poorly water-soluble and/or lipophilic drugs and are attracting major attention as alternative colloidal drug carriers. Traditional lipid-based formulations include a broad range of lipid solution, emulsions, liposomes, lipid microparticles and nanoparticles. Among the formulations above, the nanostructure lipid carriers (NLCs) are regarded as the second-generation of lipid nanoparticlesThe purpose of this study is to develop an optimized nanostructured lipid carriers (NLC) formulation for Ritonavir, and to estimate the potential of NLC as oral delivery system for poorly water-soluble drugs.